CollPlant's proprietary rhCollagen to be used in clinical and commercial applications STEMCELL Technologies supports life sciences research with more than 2,500 specialized reagents, tools, and ...
STEMCELL Technologies is announced as the co-sponsor of the ISSCR 2026 Annual Meeting - registration and abstract submission are now open. The International Society for Stem Cell Research (ISSCR) has ...
New instrument automates tissue processing for researchers in cancer, immunology and other science fields To help scientists accelerate their workflows, STEMCELL Technologies has commercially launched ...
Human pluripotent stem-cells (HPSCs)—including human embryonic stem-cells and human induced pluripotent stem-cells—are reshaping the landscape of regenerative medicine.1,2 In Parkinson's disease, ...
The liquid world of fetal development provides a rich source of nutrition and protection tailored to meet the needs of the growing fetus. In this half-day virtual summit, a series of presentations ...
From axolotls to zebrafish, stem cells possess remarkable regenerative abilities, enabling them to restore lost limbs and repair damaged organs. These extraordinary capabilities, however, are not ...
Neurona Therapeutics’ epilepsy treatment could be a breakthrough for stem-cell technology. This article first appeared in The Checkup, MIT Technology Review’s weekly biotech newsletter. To receive it ...
CollPlant's (CLGN) proprietary rhCollagen to be used in clinical and commercial applications REHOVOT, Israel, June 9, 2025 /PRNewswire/ -- CollPlant Biotechnologies, a regenerative and aesthetics ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results